Associations of different isomeric forms of serum lycopene with cardiovascular disease and all-cause mortality
Background: The effect of serum lycopene on the progression of cardiovascular diseases (CVDs) and their longevity remains a controversial topic. The purpose of this study was to evaluate the associations of different isomeric forms of serum lycopene with CVD and all-cause mortality in the American population. Methods: The National Health and Nutrition Examination Survey (NHANES) is a large population survey to investigate public health in the US. We analyzed data from 2003-2006 linked with mortality data obtained in 2015. Cox proportional hazard ratios (HRs) with 95% confidence intervals (CIs) were estimated to assess the risk of CVD and all-cause mortality caused by serum lycopene. Results: Among 7452 participants (aged 20-85 years, 46.7% male), 298 died from CVDs among the total 1213 deaths during a median follow-up of 10.7 years. Serum lycopene is a protective factor for all-cause and CVD mortality. In multivariable-adjusted models, the hazard ratio (with 95% confidence intervals) associated with Q4 compared to Q1 of serum total-lycopene, trans-lycopene and cis-lycopene was 0.49 (0.38,0.63), 0.49 (0.39,0.63) and 0.55 (0.43,0.70) for all-cause mortality (Ptrend<0.05), and was 0.53 (0.32,0.96), 0.48 (0.32,0.72) and 0.63 (0.41,0.97) for CVD mortality (Ptrend<0.05). The subgroup analyses showed that different isomeric forms of lycopene showed varied associations with CVD and all-cause mortality based on age, drinking status, history of hypertension and diabetes. Conclusions: Serum lycopene concentration was significantly associated with the risk of CVD and all-cause mortality. Cis-lycopene had a U-shaped relationship with mortality, while trans-lycopene had an inverse relationship with it.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:94 |
---|---|
Enthalten in: |
International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition - 94(2024), 2 vom: 03. Apr., Seite 108-119 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Yanan [VerfasserIn] |
---|
Links: |
---|
Themen: |
All-cause mortality |
---|
Anmerkungen: |
Date Completed 12.04.2024 Date Revised 12.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1024/0300-9831/a000775 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352026065 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM352026065 | ||
003 | DE-627 | ||
005 | 20240412232352.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1024/0300-9831/a000775 |2 doi | |
028 | 5 | 2 | |a pubmed24n1373.xml |
035 | |a (DE-627)NLM352026065 | ||
035 | |a (NLM)36691936 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Yanan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Associations of different isomeric forms of serum lycopene with cardiovascular disease and all-cause mortality |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 12.04.2024 | ||
500 | |a Date Revised 12.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Background: The effect of serum lycopene on the progression of cardiovascular diseases (CVDs) and their longevity remains a controversial topic. The purpose of this study was to evaluate the associations of different isomeric forms of serum lycopene with CVD and all-cause mortality in the American population. Methods: The National Health and Nutrition Examination Survey (NHANES) is a large population survey to investigate public health in the US. We analyzed data from 2003-2006 linked with mortality data obtained in 2015. Cox proportional hazard ratios (HRs) with 95% confidence intervals (CIs) were estimated to assess the risk of CVD and all-cause mortality caused by serum lycopene. Results: Among 7452 participants (aged 20-85 years, 46.7% male), 298 died from CVDs among the total 1213 deaths during a median follow-up of 10.7 years. Serum lycopene is a protective factor for all-cause and CVD mortality. In multivariable-adjusted models, the hazard ratio (with 95% confidence intervals) associated with Q4 compared to Q1 of serum total-lycopene, trans-lycopene and cis-lycopene was 0.49 (0.38,0.63), 0.49 (0.39,0.63) and 0.55 (0.43,0.70) for all-cause mortality (Ptrend<0.05), and was 0.53 (0.32,0.96), 0.48 (0.32,0.72) and 0.63 (0.41,0.97) for CVD mortality (Ptrend<0.05). The subgroup analyses showed that different isomeric forms of lycopene showed varied associations with CVD and all-cause mortality based on age, drinking status, history of hypertension and diabetes. Conclusions: Serum lycopene concentration was significantly associated with the risk of CVD and all-cause mortality. Cis-lycopene had a U-shaped relationship with mortality, while trans-lycopene had an inverse relationship with it | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a all-cause mortality | |
650 | 4 | |a cardiovascular mortality | |
650 | 4 | |a cohort study | |
650 | 4 | |a serum lycopene concentrations | |
650 | 7 | |a Lycopene |2 NLM | |
650 | 7 | |a SB0N2N0WV6 |2 NLM | |
700 | 1 | |a Zhai, Xiaobing |e verfasserin |4 aut | |
700 | 1 | |a Chai, Honglin |e verfasserin |4 aut | |
700 | 1 | |a Liu, Keyang |e verfasserin |4 aut | |
700 | 1 | |a Ma, Wenzhi |e verfasserin |4 aut | |
700 | 1 | |a Li, Shiyang |e verfasserin |4 aut | |
700 | 1 | |a Zeng, Jing |e verfasserin |4 aut | |
700 | 1 | |a Yang, Mei |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Feng |e verfasserin |4 aut | |
700 | 1 | |a Zheng, Surui |e verfasserin |4 aut | |
700 | 1 | |a Wu, Xia |e verfasserin |4 aut | |
700 | 1 | |a Xiang, Bing |e verfasserin |4 aut | |
700 | 1 | |a Cao, Jinhong |e verfasserin |4 aut | |
700 | 1 | |a Eshak, Ehab S |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Can |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition |d 1971 |g 94(2024), 2 vom: 03. Apr., Seite 108-119 |w (DE-627)NLM000050814 |x 0300-9831 |7 nnns |
773 | 1 | 8 | |g volume:94 |g year:2024 |g number:2 |g day:03 |g month:04 |g pages:108-119 |
856 | 4 | 0 | |u http://dx.doi.org/10.1024/0300-9831/a000775 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 94 |j 2024 |e 2 |b 03 |c 04 |h 108-119 |